COWEN AND COMPANY, LLC - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 109 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
COWEN AND COMPANY, LLC ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$23,875,868
-13.4%
460,0360.0%1.67%
-26.9%
Q2 2023$27,583,758
+37.7%
460,036
+13.5%
2.29%
-2.8%
Q1 2023$20,031,802
-13.4%
405,1740.0%2.35%
-2.7%
Q4 2022$23,123,280
-51.3%
405,174
-59.9%
2.42%
-46.8%
Q3 2022$47,488,0001,011,6704.54%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q1 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$28,523,07325.19%
Velan Capital Investment Management LP 200,000$9,888,0008.43%
RTW INVESTMENTS, LP 5,649,943$279,333,1825.82%
Paradigm Biocapital Advisors LP 1,126,256$55,682,0975.28%
Rock Springs Capital Management LP 3,001,662$148,402,1693.54%
Logos Global Management LP 500,000$24,720,0003.54%
TANG CAPITAL MANAGEMENT LLC 405,600$20,052,8642.99%
GREAT POINT PARTNERS LLC 255,367$12,625,3442.48%
COWEN AND COMPANY, LLC 405,174$20,031,8022.35%
Eschler Asset Management LLP 60,000$2,966,4002.34%
View complete list of IMMUNOCORE HLDGS PLC shareholders